Dr. Reddy’s seeks DCGI nod for Sputnik-V phase-3 trials

Pharma major Dr. Reddy’s Laboratories on Monday said safety data pertaining to phase-2 clinical trial of Russia’s Sputnik-V COVID-19 vaccine candidate

from The Hindu - Home https://ift.tt/38Clqhn
https://ift.tt/2IyLjhI